Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Matrix metalloproteinases and tumor progression.

José M P Freije1, Milagros Balbín, Alberto M Pendás

  • 1Departamento de Bioquímica, Instituto Universitario de Oncología, Universidad de Oviedo, 33006-Oviedo, Spain.

Advances in Experimental Medicine and Biology
|August 12, 2003
PubMed
Summary

Matrix metalloproteinases (MMPs) are crucial in tumor progression and metastasis. Targeting specific MMPs early in cancer may be more effective than broad-spectrum inhibitors used late in the disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Homeodynamic Rejuvenation: an adaptive framework for resetting skin aging.

Frontiers in aging·2026
Same author

Pro-aging effects of chronic glucocorticoid signaling.

Cell metabolism·2026
Same author

Exercise-induced changes in physical performance and circulating acyl-CoA binding protein/diazepam binding inhibitor (ACBP/DBI) in older adults with and without HIV.

The journals of gerontology. Series A, Biological sciences and medical sciences·2026
Same author

The long-lived immune system of centenarians.

Nature reviews. Immunology·2026
Same author

Exercise and the hallmarks of cardiovascular aging.

Ageing research reviews·2026
Same author

Correction: LPS responsiveness and neutrophil chemotaxis in vivo require PMN MMP-8 activity.

PloS one·2025

Area of Science:

  • Oncology
  • Biochemistry
  • Enzymology

Background:

  • Matrix metalloproteinases (MMPs) are enzymes often overexpressed in human tumors.
  • MMPs facilitate tumor invasion and metastasis by degrading extracellular matrix.
  • They also influence tumor cell proliferation and angiogenesis.

Purpose of the Study:

  • To review the role of MMPs in cancer progression.
  • To discuss the limitations of current MMP inhibitor strategies.
  • To explore novel approaches for targeting MMPs in cancer therapy.

Main Methods:

  • Review of existing literature on MMPs in cancer.
  • Analysis of clinical trial outcomes for MMP inhibitors.
  • Discussion of emerging concepts like tumor degradome and protease analysis.

Related Experiment Videos

Main Results:

  • First-generation MMP inhibitors have shown limited success in advanced cancer.
  • Reasons for failure include targeting the wrong MMPs or disease stages.
  • Selective inhibition of specific MMPs early in tumor evolution shows promise.

Conclusions:

  • Targeting specific MMPs, rather than using broad-spectrum inhibitors, may improve cancer treatment efficacy.
  • Identifying relevant MMPs for individual cancers is crucial.
  • Further research is needed to determine the role of MMP inhibition in future cancer therapeutics.